EPOR Antibody Blocking Peptide(bs-1424P)-500ug

EPOR Antibody Blocking Peptide

(bs-1424P)-500ug
收藏
  • ¥880
  • Bioss已认证
  • bs-1424P
  • 2025年10月16日
    avatar
    品牌商
    9钻石会员
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 技术资料
    • 规格

      500ug

    产品编号bs-1424P
    英文名称EPOR Antibody Blocking Peptide
    中文名称红细胞生成素受体封闭多肽
    英文别名erythropoietin receptor; EPO R; EPO Receptor; Erythropoietin receptor precursor; EPOR_HUMAN; MGC138358.
    性状Lyophilized
    纯化方法HPLC
    研究领域

    Cardiovascular > Angiogenesis > Angiogenic Factors

    Cardiovascular > Angiogenesis > Endothelial Cell Markers

    Cardiovascular > Atherosclerosis > Ischemia / Reperfusion

    Cardiovascular > Heart > Apoptosis

    Cardiovascular > Heart > Hypertrophy

    Immunology > Immunoglobulins > Receptors

    Signal Transduction > Signaling Pathway > G Protein Signaling > Small G Proteins

    Stem Cells > Hematopoietic Progenitors > Surface Molecules

    亚基Forms homodimers on EPO stimulation. The tyrosine-phosphorylated form interacts with several SH2 domain-containing proteins including LYN, the adapter protein APS, PTPN6, PTPN11, JAK2, PI3 kinases, STAT5A/B, SOCS3, CRKL. Interacts with INPP5D/SHIP1. The N-terminal SH2 domain of PTPN6 binds Tyr-454 and inhibits signaling through dephosphorylation of JAK2. APS binding also inhibits the JAK-STAT signaling. Binding to PTPN11, preferentially through the N-terminal SH2 domain, promotes mitogenesis and phosphorylation of PTPN11. Binding of JAK2 (through its N-terminal) promotes cell-surface expression. Interaction with the ubiquitin ligase NOSIP mediates EPO-induced cell proliferation. Interacts with ATXN2L.
    亚细胞定位Cell membrane; Single-pass type I membrane protein.
    Isoform EPOR-S: Secreted. Note=Secreted and located to the cell surface.
    组织特异性Erythroid cells and erythroid progenitor cells. Isoform EPOR-F is the most abundant form in EPO-dependent erythroleukemia cells and in late-stage erythroid progenitors. Isoform EPOR-S and isoform EPOR-T are the predominant forms in bone marrow. Isoform EPOR-T is the most abundant from in early-stage erythroid progenitor cells.
    翻译后修饰On EPO stimulation, phosphorylated on C-terminal tyrosine residues by JAK2. The phosphotyrosine motifs are also recruitment sites for several SH2-containing proteins and adapter proteins which mediate cell proliferation. Phosphorylation on Tyr-454 is required for PTPN6 interaction, Tyr-426 for PTPN11. Tyr-426 is also required for SOCS3 binding, but Tyr-454/Tyr-456 motif is the preferred binding site.
    Ubiquitinated by NOSIP; appears to be either multi-monoubiquitinated or polyubiquitinated. Ubiquitination mediates proliferation and survival of EPO-dependent cells.
    相似性Belongs to the type I cytokine receptor family. Type 1 subfamily. Contains 1 fibronectin type-III domain.
    功能Receptor for erythropoietin. Mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase. Isoform EPOR-T acts as a dominant-negative receptor of EPOR-mediated signaling.
    保存条件Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles.
    背景资料The erythropoietin receptor (EPOR) is a member of the cytokine receptor family. There are several isoforms including: EPOR-F (full length), EPOR-S (soluble form), and EPOR-T (truncated form). Upon erythropoietin (EPO) binding, the EPOR activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated EPOR appears to have a role in erythroid cell survival. Defects in the EPOR may produce erythroleukemia and familial erythrocytosis. A functional EPOR is found in the cardiovascular system, including endothelial cells and cardiomyocytes, and data suggest that the EPO/EPO receptor system plays an important role in cardiac function. In animal studies, treatment with EPO during ischemia/reperfusion in the heart has been shown to limit the infarct size and the extent of apoptosis.

     

     

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥880
    北京博奥森生物技术有限公司
    2025年10月16日询价
    ¥7237
    武汉博欧特生物科技有限公司
    2025年05月05日询价
    ¥1759.50
    深圳欣博盛生物科技有限公司
    2025年07月16日询价
    ¥3784.50
    西宝生物科技(上海)股份有限公司
    2025年07月04日询价
    ¥1
    瑞博奥(广州)生物科技股份有限公司
    2025年07月11日询价
    EPOR Antibody Blocking Peptide(bs-1424P)-500ug
    ¥880